Patient monitors are life-critical medical devices used in hospitals, ICUs, operation theatres, emergency departments, and home care settings across India. Whether you are a domestic manufacturer, a foreign OEM, or an Indian importer of patient monitoring equipment, obtaining CDSCO registration is a mandatory legal requirement before your device can be legally sold, distributed, or used commercially in India.
We offer specialised CDSCO registration services for patient monitors — from device classification and technical documentation to application filing, query response, and final approval. Our regulatory experts ensure your device meets every requirement under Indian medical device law, so you can bring your product to market without delays.
The Central Drugs Standard Control Organisation (CDSCO) is India’s national regulatory authority for medical devices, functioning under the Ministry of Health and Family Welfare. Under the Medical Devices Rules, 2017 (MDR 2017), all medical devices — including patient monitors — must be registered with CDSCO before they can be manufactured for sale or imported into India.
CDSCO registration is the formal process through which a medical device is evaluated for safety, quality, and performance, and granted a Market Authorisation that permits its commercial placement in India.
For imported patient monitors, the application is filed in Form MD-14 (import licence application). For domestically manufactured patient monitors, the application is filed in Form MD-5 (manufacturing licence application). Both are submitted through the SUGAM online portal of CDSCO.
Under Indian and international medical device classification frameworks, a patient monitor is an active medical device used to continuously measure, display, record, and/or alarm on one or more physiological parameters of a patient. These parameters typically include:
Patient monitors range from basic bedside monitors (used in general wards) to highly complex multi-parameter ICU monitors, transport monitors, anaesthesia workstations with integrated monitoring, foetal monitors, and wearable remote patient monitoring devices.
Patient monitors directly interface with critically ill patients and support life-threatening clinical decisions. A malfunctioning or inaccurate patient monitor can lead to misdiagnosis, delayed intervention, and patient harm. Recognising this, the Government of India has classified patient monitors as regulated medical devices under Schedule I of the Medical Devices Rules, 2017.
Legal Consequences of Non-Compliance:
Under the Medical Devices Rules, 2017, medical devices are classified into four risk-based classes. Patient monitors are generally classified as follows:
Device Type | Risk Class | Regulatory Pathway |
Basic bedside monitor (SpO₂, NIBP, ECG — standalone display) | Class B | Self-certification with State Licensing Authority / CDSCO |
Multi-parameter patient monitor (ICU, OT grade) | Class C | CDSCO Central Licence — Third Party Audit / Notified Body |
Advanced ICU monitor with invasive haemodynamic monitoring | Class C | CDSCO Central Licence — Notified Body |
Implantable or life-sustaining monitoring components | Class D | CDSCO Central Licence — Stricter conformity assessment |
Wearable / remote patient monitoring devices | Class B / C | Based on intended use and risk profile |
Foetal monitors | Class C | CDSCO Central Licence |
Transport / portable monitors | Class C | CDSCO Central Licence |
Classification must be formally determined at the start of the registration process, as it directly determines the required conformity assessment route, applicable standards, and the licensing authority.
Required for any entity importing patient monitors manufactured outside India. The licence is issued by CDSCO and is product-specific and manufacturer-specific.
Required for domestic manufacturers of patient monitors in India. Issued by the State Licensing Authority (SLA) for Class A and Class B devices, and by CDSCO for Class C and Class D devices.
For manufacturers who wish to manufacture patient monitors using the premises and equipment of another licensed manufacturer.
For entities that repackage or relabel imported patient monitors before distribution in India.
Test reports must be issued by NABL-accredited laboratories or laboratories accredited by equivalent international bodies (ILAC, A2LA, etc.).
IFU must be available in English. Translations may be required based on regulatory requirements.
Determine the correct classification of your patient monitor under MDR 2017. Identify the applicable conformity assessment route, required standards, and licensing authority (State or Central).
Conduct a thorough review of all available technical, clinical, and quality documents against CDSCO requirements. Identify gaps and plan corrective actions.
Verify that all required IEC/ISO test reports are available, current, and issued by acceptable laboratories. Commission additional testing if required.
Prepare or review the Clinical Evaluation Report to ensure it meets CDSCO expectations and is supported by adequate clinical evidence.
Create and verify the applicant account on the CDSCO SUGAM portal (sugam.gov.in). Set up Digital Signature Certificate (DSC) access.
Compile the complete application dossier with all required documents, properly indexed and formatted for SUGAM portal upload.
Submit the completed application through the SUGAM portal and pay the prescribed government fee online.
CDSCO examines the submitted dossier. For Class C and Class D devices, a Third Party Audit (TPA) or Notified Body assessment may be required. CDSCO may raise technical queries.
Our team responds to all CDSCO queries promptly with accurate, well-supported technical responses to avoid further rounds of clarification.
For domestic manufacturers or complex Class C/D devices, CDSCO or an appointed auditor may conduct an on-site inspection of manufacturing premises or review quality systems.
Upon successful evaluation, CDSCO issues the Import Licence (Form MD-15) or Manufacturing Licence (Form MD-6) for the patient monitor. The certificate is available digitally through the SUGAM portal.
Establish procedures for post-market surveillance, vigilance reporting, periodic safety update reports (PSURs), and licence renewal tracking.
Application Type | Government Fee |
Import Licence — Class A / B devices | ₹5,000 per device |
Import Licence — Class C / D devices | ₹50,000 per device |
Manufacturing Licence — Class A / B | ₹5,000 |
Manufacturing Licence — Class C / D | ₹50,000 |
Renewal of Import / Manufacturing Licence | 50% of original fee |
Amendment to existing licence | ₹2,500 – ₹10,000 |
Addition of new device model to existing licence | As applicable per class |
Fees are payable online through the SUGAM portal. Fees are subject to revision by the Government of India. Always verify current fees on the SUGAM portal before application.
Device Class | Estimated Timeline |
Class B — Simple multi-parameter monitor | 3 – 6 months |
Class C — Advanced ICU / OT multi-parameter monitor | 6 – 12 months |
Class C — Foetal monitor / transport monitor | 6 – 12 months |
Class D — Complex life-sustaining monitors | 12 – 18 months |
Timelines are estimates and depend on document completeness, CDSCO workload, query resolution speed, and whether Third Party Audit / Notified Body assessment is required.
Deep Medical Device Regulatory Expertise Our team has specialised knowledge of CDSCO requirements for active medical devices including patient monitors. We understand the technical standards, clinical evaluation methodology, and CDSCO review expectations specific to this device category.
End-to-End Dossier Preparation We prepare your complete CDSCO registration dossier — from Essential Principles checklist and Risk Management File to Clinical Evaluation Report and labelling review — ensuring every document meets regulatory standards.
Standards Compliance Review We verify that your test reports cover all applicable IEC 60601 and ISO standards required for patient monitors and advise on any gaps before application submission.
SUGAM Portal Management We handle the complete SUGAM portal application process — account setup, form filling, document upload, fee payment coordination, and application tracking.
Query and Deficiency Response CDSCO queries are handled by our experts with technically precise, well-documented responses that resolve issues efficiently and avoid repeated rounds of correspondence.
Post-Registration Support We support you with ongoing compliance — post-market surveillance planning, vigilance reporting, licence renewal, and amendment applications as your product range evolves.
Transparent Timelines and Communication You receive regular status updates and clear milestone tracking throughout the registration process. No surprises, no hidden bottlenecks.
Q1. Is CDSCO registration mandatory for all patient monitors sold in India? Yes. All patient monitors placed on the Indian market — whether imported or domestically manufactured — must be registered with CDSCO under the Medical Devices Rules, 2017. Operating without registration is a criminal offence.
Q2. Can a hospital import a patient monitor for its own use without CDSCO registration? No. Even for institutional end-use, patient monitors must be registered with CDSCO. Government hospitals and procurement bodies are required to verify CDSCO registration before purchasing medical devices.
Q3. How many device models can be covered under one CDSCO application? Generally, each model of patient monitor requires a separate application. Minor variants (colour variants, power supply variants) may sometimes be covered under a single application depending on their technical differences. Our team can advise on the optimal registration strategy for your product range.
Q4. Is CE marking or US FDA clearance sufficient to sell patient monitors in India? No. CE marking and FDA clearance are recognised as evidence of conformity in their respective markets, but they do not replace CDSCO registration in India. CDSCO conducts its own review and requires India-specific documentation. However, CE or FDA approval documents (such as the Certificate of Conformity or 510(k) clearance) are required as supporting documentation in the CDSCO application.
Q5. What is a Third Party Audit (TPA) in the context of CDSCO registration? For Class C and Class D medical devices, CDSCO requires an independent quality audit of the technical dossier by an approved Third Party Auditor or Notified Body before the licence is granted. The TPA reviews the documentation and may recommend approval, request clarifications, or highlight deficiencies.
Q6. Can a foreign manufacturer apply for CDSCO registration directly? No. Foreign manufacturers must appoint an Indian Authorised Agent (IAA) — an entity legally registered in India — who applies for the import licence on their behalf. The IAA bears regulatory responsibility for the device in India.
Q7. What happens if my patient monitor has a software component — does it need separate registration? Software that forms an integral part of the patient monitor (embedded firmware) is covered under the device registration. However, standalone medical device software (SAMD) that independently performs patient monitoring functions may require its own separate CDSCO registration as a software-only medical device.
Q8. Do wearable patient monitoring devices follow the same registration process? Yes, wearable patient monitoring devices are regulated as medical devices under MDR 2017 and require CDSCO registration. Their classification (Class B or C) depends on the parameters monitored, intended use, and clinical risk profile.
